Press Releases

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced the appointment of Ms. Shirley Zhao to the position of General Manager for Greater China and Head of Commercial. In this position, Ms. Zhao will be responsible for the commercializa

STOCKHOLM, Dec. 6, 2019 /PRNewswire/ -- Biovica, active in cancer diagnostics, today announced that Henrik Winther was appointed SVP Business Development and will be part of the management team. He most recently comes from the role of SVP Precision Diagnostics at Immunovia."Henrik possesses a rare combination of scientific exp

EVANS, Colo., Dec. 5, 2019 /PRNewswire/ -- A recent incident at Sunrise Community Health ("Sunrise") may affect the privacy of certain information. Sunrise is unaware of any actual or attempted misuse of this information. However, Sunrise is providing notification to individuals whose information was present in Sunrise email accounts accessed by an unauthorized indi

SUZHOU, China, Dec. 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced that the first patient has been successfully dosed in a Phase I clin

NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Healthcare Trust, Inc. ("HTI" or the "Company") today announced the pricing of an underwritten public offering of 1,400,000 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") at a public offering price of $25.00 per share. In addition, the

WINNIPEG, Dec. 5, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced that it has reached a settlement agreement with the purchaser of Medicure's interests in Apicore with respect to the amounts heldback under the Apicore sale agreement. A settlement agreement was re

MECHANICSBURG, Pa., Dec. 5, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has priced its private placement of $675 million aggregate principal amount of its 6.250% senior notes due 2026 (the "Additional Notes") as additional notes under the indent

SILVER SPRING, Md., Dec. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has been investigating the presence of genotoxic impurities, called nitrosamines, in some types of drugs. Over the past year and a half, several drug products including angiotensin II receptor blockers (ARBs) and ranitidine, commonly known as Zantac, have been found to contain small am

NEW HAVEN, Conn., Dec. 5, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical stage biopharmaceutical company with a portfolio of late-stage product candidates for neurological and neuropsychiatric diseases, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat. No. 10,485,

WILMINGTON, N.C., Dec. 5, 2019 /PRNewswire/ -- Hensler Surgical Products, LLC, dba Hensler Surgical Technologies (www.henslersurgical.com) today filed a federal lawsuit in